Johnson & Johnson announced Friday that its single-dose vaccine was 66% effective globally in preventing COVID-19, and 72% effective in the United States. The company plans to seek emergency use..
A fourth coronavirus vaccine could be approved for use in the UK within weeks as late-stage trials suggested it was 89% effective in preventing Covid-19.
The UK has secured 60 million doses of the..